CXCR2 and neoplasm: Indeed, the diverse cell types in the TME (e.g., tumor cells, immune cells, fibroblasts) release large quantities of CXCR2 ligands, forming a chemotactic gradient that attracts the neutrophils from the bloodstream (29).